A bit surprised that that wasn't the plan in the first place. Normally that's where it should start, at the place of the invention. IMU and RAD did it that way and CHM with CHM 1101 as well. But always great to see that the scientists are excited and convinced while the ASX market values it as crap.
What we now need is one of the CAR-T giants knocking on the door to participate, to show the market that CDH17 isn't just a dream but a real force to reckon with. I still have some hope that JC was sent out to get that partnership going, a win for that pharma, for CHM and for JC - not to mention the sufferers and us little holders.
GLTA
Ann: University of Pennsylvania joins CHM CDH17 Phase 1/2 trial, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $11.72K | 2.783M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2757364 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 15260220 | 25 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |